Nearly one-third of clinical trial sites expect the novel coronavirus will have a “big or extremely big” impact on their ability to recruit patients for new trials or keep patients already enrolled in existing studies compliant with scheduling, a new survey finds.
In addition, 39% of 170 clinical trial sites surveyed in the U.S. believe patients will be much less or somewhat less likely to enroll in new clinical research trials. And 25% of the sites expect patients currently enrolled in a trial to be much less or somewhat less willing to continue their participation.
Drilling down a bit, non-academic hospital sites were more likely to say that recruiting new patients has been challenging. But trial sites located in academic institutions were more likely to report that retaining currently enrolled patients has been “the biggest challenge.”
About the Author Reprints
